GLP-1 drugs The most common side effects are digestive, including nausea, vomiting, diarrhea, and constipation
This caution is solely based on data from rodent studies and is not unique for semaglutide amongst the GLP-1RA
People who have a certain type of thyroid cancer, which is medullary thyroid cancer, is very specific and it's very rare, they cannot use that, okay, it's a big no-no, Ortiz said
Ivim Health is exploring how carefully calibrated low doses of GLP-1 medications like semaglutide and tirzepatide can support long-term wellness in ways that go beyond the scale
The discontinuation profile proves more favorable than retinoids showing rapid rebound and high dependency, while similar to vitamin C and niacinamide demonstrating moderate benefit retention and low dependency patterns
The American Heart Association's 2023 AF anticoagulation guidance lists metabolic syndrome and obesity-related NAFLD as independent factors that alter warfarin sensitivity, which supports heightened vigilance in exactly the patient population receiving triple agonists